Pancrelipase (Solvay Pharmaceuticals)

胰酶（Solvay Pharmaceuticals）

Report date: 2026/05/20 20:02:01

Base Information

Drug NamePancrelipase (Solvay Pharmaceuticals)
Drug Alias NameLipacreonCreonABT-SLV-245SA-001 (Solvay Pharmaceuticals)
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionPancrelipase replacements
TargetsPancrelipase
Therapy Area/IndicationsDyspepsiaPancreatitis, ChronicPancreatitis +[8] 
Global Approved IndicationsDyspepsiaExocrine Pancreatic Insufficiency
Approved Indications in ChinaDyspepsia
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryUnited StatesRussian FederationMainland China +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie IncSolvay Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAbbott Arzneimittel GmbhAbbott Products GmbhShanghai Changzheng Hospital +[6] 
Inactive CompaniesAbbott LaboratoriesAbbott ProductsSolvay Pharmaceuticals
Active IndicationsDyspepsiaPancreatitis, ChronicPancreatitis +[6] 
Inactive IndicationsShort Bowel SyndromeNeoplasms

Other Information

ATC CodeA09AA02
Related LinksDrugBank